XORTX Historical Financial Ratios

XRTX Stock

USD 1.21 0.02 1.68%

XORTX Therapeutics is currently reporting on over 87 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0, PTB Ratio of 0.89 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate XORTX Therapeutics financial condition quickly.

Quick Ratio Current Ratio

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

About XORTX Financial Ratios Analysis

XORTX TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate XORTX Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on XORTX financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across XORTX Therapeutics history.

XORTX Therapeutics Financial Ratios Chart

At this time, XORTX Therapeutics' Payables Turnover is fairly stable compared to the past year. Cash Per Share is likely to rise to 2.09 in 2024, whereas PTB Ratio is likely to drop 0.89 in 2024.

Average Payables Ev To Sales Payables Turnover Cash Per Share Days Payables Outstanding Earnings Yield

Add Fundamental

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Earnings Yield

The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.

Most ratios from XORTX Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into XORTX Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.At this time, XORTX Therapeutics' Payables Turnover is fairly stable compared to the past year. Cash Per Share is likely to rise to 2.09 in 2024, whereas PTB Ratio is likely to drop 0.89 in 2024.

XORTX Therapeutics fundamentals Correlations

	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow
Ptb Ratio		0.44	-0.01	-0.52	-0.13	0.53	1.0	-0.55	-0.86	-0.1	-0.38	0.13	-0.03	-0.19	0.34	0.29	-0.25	-0.04	0.26	-0.41	0.31	-0.62	0.31	-0.24	0.18	0.28
Book Value Per Share	0.44		-0.04	-0.74	0.54	0.33	0.44	-0.75	-0.39	-0.17	0.06	0.19	0.04	-0.11	0.89	-0.57	-0.61	0.12	-0.6	-0.03	0.62	-0.06	-0.53	-0.87	0.42	-0.57
Free Cash Flow Yield	-0.01	-0.04		0.36	-0.1	0.46	-0.01	0.34	0.3	0.82	-0.08	-0.77	-0.99	-0.83	0.03	-0.33	0.66	-0.21	-0.29	0.84	-0.44	0.06	-0.33	-0.23	-0.18	-0.29
Operating Cash Flow Per Share	-0.52	-0.74	0.36		-0.51	-0.02	-0.52	1.0	0.61	0.67	0.38	-0.7	-0.35	0.1	-0.73	0.21	0.84	-0.29	0.26	0.33	-0.44	0.29	0.18	0.39	-0.34	0.23
Average Payables	-0.13	0.54	-0.1	-0.51		-0.4	-0.13	-0.45	-0.05	-0.35	-0.17	0.38	0.13	-0.09	0.58	-0.59	-0.56	0.6	-0.63	0.15	-0.03	0.1	-0.56	-0.37	0.32	-0.6
Capex To Depreciation	0.53	0.33	0.46	-0.02	-0.4		0.53	-0.07	-0.23	0.59	-0.1	-0.58	-0.52	-0.3	0.23	-0.21	0.3	-0.48	-0.19	0.21	0.2	-0.41	-0.21	-0.49	-0.21	-0.19
Pb Ratio	1.0	0.44	-0.01	-0.52	-0.13	0.53		-0.55	-0.86	-0.1	-0.38	0.13	-0.03	-0.19	0.34	0.29	-0.25	-0.04	0.26	-0.41	0.31	-0.62	0.31	-0.24	0.18	0.28
Free Cash Flow Per Share	-0.55	-0.75	0.34	1.0	-0.45	-0.07	-0.55		0.63	0.64	0.34	-0.68	-0.32	0.11	-0.71	0.19	0.81	-0.21	0.24	0.33	-0.5	0.29	0.16	0.4	-0.37	0.22
Roic	-0.86	-0.39	0.3	0.61	-0.05	-0.23	-0.86	0.63		0.34	0.44	-0.35	-0.25	-0.04	-0.21	-0.35	0.36	-0.12	-0.3	0.51	-0.37	0.76	-0.37	0.04	-0.48	-0.31
Inventory Turnover	-0.1	-0.17	0.82	0.67	-0.35	0.59	-0.1	0.64	0.34		0.19	-1.0	-0.84	-0.39	-0.23	-0.24	0.85	-0.41	-0.19	0.69	-0.28	0.01	-0.25	-0.2	-0.21	-0.2
Net Income Per Share	-0.38	0.06	-0.08	0.38	-0.17	-0.1	-0.38	0.34	0.44	0.19		-0.23	0.07	0.33	-0.15	-0.11	0.14	-0.48	-0.08	-0.01	0.53	0.73	-0.11	-0.19	0.16	-0.09
Days Of Inventory On Hand	0.13	0.19	-0.77	-0.7	0.38	-0.58	0.13	-0.68	-0.35	-1.0	-0.23		0.79	0.31	0.26	0.22	-0.85	0.41	0.18	-0.65	0.25	-0.01	0.23	0.19	0.21	0.19
Payables Turnover	-0.03	0.04	-0.99	-0.35	0.13	-0.52	-0.03	-0.32	-0.25	-0.84	0.07	0.79		0.83	0.02	0.32	-0.7	0.31	0.29	-0.84	0.38	0.0	0.33	0.21	0.16	0.29
Average Inventory	-0.19	-0.11	-0.83	0.1	-0.09	-0.3	-0.19	0.11	-0.04	-0.39	0.33	0.31	0.83		-0.2	0.27	-0.31	0.12	0.25	-0.68	0.35	0.02	0.26	0.14	0.06	0.25
Cash Per Share	0.34	0.89	0.03	-0.73	0.58	0.23	0.34	-0.71	-0.21	-0.23	-0.15	0.26	0.02	-0.2		-0.56	-0.69	0.38	-0.58	0.02	0.33	0.01	-0.51	-0.86	0.2	-0.54
Pocfratio	0.29	-0.57	-0.33	0.21	-0.59	-0.21	0.29	0.19	-0.35	-0.24	-0.11	0.22	0.32	0.27	-0.56		0.12	0.0	1.0	-0.58	-0.05	-0.24	1.0	0.67	0.07	1.0
Interest Coverage	-0.25	-0.61	0.66	0.84	-0.56	0.3	-0.25	0.81	0.36	0.85	0.14	-0.85	-0.7	-0.31	-0.69	0.12		-0.49	0.16	0.57	-0.44	-0.01	0.08	0.34	-0.26	0.13
Capex To Operating Cash Flow	-0.04	0.12	-0.21	-0.29	0.6	-0.48	-0.04	-0.21	-0.12	-0.41	-0.48	0.41	0.31	0.12	0.38	0.0	-0.49		-0.04	-0.11	-0.35	-0.16	0.05	-0.09	0.23	0.01
Pfcf Ratio	0.26	-0.6	-0.29	0.26	-0.63	-0.19	0.26	0.24	-0.3	-0.19	-0.08	0.18	0.29	0.25	-0.58	1.0	0.16	-0.04		-0.56	-0.07	-0.21	0.99	0.67	0.02	1.0
Days Payables Outstanding	-0.41	-0.03	0.84	0.33	0.15	0.21	-0.41	0.33	0.51	0.69	-0.01	-0.65	-0.84	-0.68	0.02	-0.58	0.57	-0.11	-0.56		-0.41	0.18	-0.59	-0.22	-0.05	-0.56
Income Quality	0.31	0.62	-0.44	-0.44	-0.03	0.2	0.31	-0.5	-0.37	-0.28	0.53	0.25	0.38	0.35	0.33	-0.05	-0.44	-0.35	-0.07	-0.41		0.08	-0.03	-0.45	0.53	-0.06
Roe	-0.62	-0.06	0.06	0.29	0.1	-0.41	-0.62	0.29	0.76	0.01	0.73	-0.01	0.0	0.02	0.01	-0.24	-0.01	-0.16	-0.21	0.18	0.08		-0.25	-0.1	-0.15	-0.21
Ev To Operating Cash Flow	0.31	-0.53	-0.33	0.18	-0.56	-0.21	0.31	0.16	-0.37	-0.25	-0.11	0.23	0.33	0.26	-0.51	1.0	0.08	0.05	0.99	-0.59	-0.03	-0.25		0.62	0.11	1.0
Pe Ratio	-0.24	-0.87	-0.23	0.39	-0.37	-0.49	-0.24	0.4	0.04	-0.2	-0.19	0.19	0.21	0.14	-0.86	0.67	0.34	-0.09	0.67	-0.22	-0.45	-0.1	0.62		-0.22	0.63
Return On Tangible Assets	0.18	0.42	-0.18	-0.34	0.32	-0.21	0.18	-0.37	-0.48	-0.21	0.16	0.21	0.16	0.06	0.2	0.07	-0.26	0.23	0.02	-0.05	0.53	-0.15	0.11	-0.22		0.06
Ev To Free Cash Flow	0.28	-0.57	-0.29	0.23	-0.6	-0.19	0.28	0.22	-0.31	-0.2	-0.09	0.19	0.29	0.25	-0.54	1.0	0.13	0.01	1.0	-0.56	-0.06	-0.21	1.0	0.63	0.06

Click cells to compare fundamentals

XORTX Therapeutics Account Relationship Matchups

XORTX Therapeutics fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Ptb Ratio	(47.56)	9.03	16.81	19.25	0.93	0.89
Book Value Per Share	0.55	(0.36)	1.7	12.04	4.71	2.34
Free Cash Flow Yield	(0.0255)	(0.0655)	(0.0217)	(0.066)	(1.53)	(1.45)
Operating Cash Flow Per Share	(0.42)	(0.98)	(4.36)	(5.96)	(3.32)	(3.49)
Capex To Depreciation	0.35	0.7	2.23	0.8	0.45	0.43
Pb Ratio	(47.56)	9.03	16.81	19.25	0.93	0.89
Free Cash Flow Per Share	(0.43)	(1.0)	(4.39)	(5.99)	(3.35)	(3.51)
Roic	3.73	(1.05)	(0.32)	(1.53)	(1.04)	(0.98)
Net Income Per Share	(1.06)	(1.73)	(1.19)	(4.72)	(1.44)	(1.52)
Payables Turnover	0.0328	0.0668	0.0552	0.0582	0.72	0.76
Cash Per Share	0.0984	0.23	13.56	7.03	1.74	2.09
Pocfratio	(40.35)	(15.57)	(46.42)	(15.22)	(0.66)	(0.69)
Interest Coverage	(51.9)	(15.21)	(96.25)	(941.98)	(1.1K)	(1.0K)
Capex To Operating Cash Flow	(0.0282)	(0.0197)	(0.006566)	(0.005015)	(0.007157)	(0.007515)
Pfcf Ratio	(39.24)	(15.27)	(46.12)	(15.15)	(0.65)	(0.69)
Days Payables Outstanding	11.1K	5.5K	6.6K	6.3K	503.47	478.3
Income Quality	0.4	0.57	3.67	1.26	3.05	3.2
Roe	2.97	(1.02)	(0.0987)	(1.0)	(0.62)	(0.65)
Ev To Operating Cash Flow	(5.03)	(40.32)	(15.34)	(43.31)	(14.05)	(0.14)
Pe Ratio	(15.99)	(8.83)	(170.33)	(19.21)	(1.52)	(1.59)
Return On Tangible Assets	(0.77)	(0.62)	(0.0759)	(0.58)	(0.54)	(0.57)
Ev To Free Cash Flow	(4.9)	(39.21)	(15.04)	(43.03)	(13.98)	(0.14)
Earnings Yield	(0.0625)	(0.11)	(0.005871)	(0.0521)	(0.66)	(0.63)
Intangibles To Total Assets	0.25	0.1	0.0116	0.0162	0.0321	0.0304
Net Debt To E B I T D A	0.0136	0.14	9.08	1.1	0.53	0.92
Current Ratio	0.63	1.99	3.81	7.19	13.8	14.49
Tangible Book Value Per Share	(0.81)	1.38	11.86	4.58	2.25	1.22
Graham Number	2.91	8.14	17.95	22.38	8.72	8.38
Shareholders Equity Per Share	0.55	(0.36)	1.7	12.04	4.71	2.34
Capex Per Share	0.0118	0.0194	0.0286	0.0299	0.0238	0.0226
Interest Debt Per Share	0.11	0.15	0.0182	0.004028	0.004632	0.004401
Enterprise Value Over E B I T D A	(17.58)	(8.93)	(126.44)	(13.17)	(0.14)	(0.15)
Price Earnings Ratio	(15.99)	(8.83)	(170.33)	(19.21)	(1.52)	(1.59)
Price Book Value Ratio	(47.56)	9.03	16.81	19.25	0.93	0.89
Price Earnings To Growth Ratio	0.19	(0.14)	5.46	(0.0648)	0.0218	0.0207

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

XORTX Historical Financial Ratios

About XORTX Financial Ratios Analysis

XORTX Therapeutics Financial Ratios Chart

Average Payables

Ev To Sales

Payables Turnover

Earnings Yield

XORTX Therapeutics fundamentals Correlations

XORTX Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

XORTX Therapeutics fundamentals Accounts

Also Currently Popular

Additional Tools for XORTX Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Ev To Free Cash Flow	+ 1.0	Pocfratio
Ev To Free Cash Flow	+ 1.0	Pfcf Ratio

Days Of Inventory On Hand	- 1.0	Inventory Turnover
Payables Turnover	- 0.99	Free Cash Flow Yield
Pe Ratio	- 0.87	Book Value Per Share
Pe Ratio	- 0.86	Cash Per Share
Roic	- 0.86	Pb Ratio
Roic	- 0.86	Ptb Ratio